Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient population. The company produces anabolic/catabolic transforming agents to treat cachexia, an often deadly syndrome linked with a wide range of chronic illnesses, allowing healthcare providers to manage cancer-related cachexia. Actimed was founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead.
Domain
actimedtherapeutics.com
Country
United KingdomIndustry
BiotechnologyEmployees
1-10
Last Funding
$6.0M
Founded
2016
Tech Stack (20 technologies)
Frequently Asked Questions
What technologies does Actimed Therapeutics use?+
Actimed Therapeutics uses 20 technologies including Cookie Control, Font Awesome, Google Analytics.
What industry is Actimed Therapeutics in?+
Actimed Therapeutics operates in the Biotechnology industry.
Where is Actimed Therapeutics based?+
Actimed Therapeutics is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026